Innogen · News · March 19, 2012

Governing Synthetic Biology

Syn Bio

Read the latest in the Appropriate Governance of Life Science briefing series by Joyce Tait


Appropriate Governance of the Life Sciences (AGLS) is a series of policy briefs describing Innogen's research on:



  • Strategic innovation issues in life sciences

  • The governance and regulation of innovation

  • The resulting innovation trajectories determining which products are developed and which companies take the lead in developing them


Governing Synthetic Biology:

The appropriate risk governance concept, developed by the ESRC Innogen Centre, is enabling of innovation, minimises risk to people and the environment, and balances the interests and values of all relevant stakeholders.


Synthetic biology is one important illustration of how rapid advances in the life sciences are opening up potentially important new applications in medicine and healthcare, agriculture, industrial chemistry and energy production. Credible, effective and appropriate governance systems are a key part of ensuring that the benefits of synthetic biology are realised while minimising risks.


This policy brief is based on a policy brief prepared for the International Risk Governance Council (www.irgc.org).

Download AGLS (11): Governing Synthetic Biology (PDF 985 KB)


Review the whole Appropriate Governance of the Life Science (AGLS) briefing series